Literature DB >> 25943180

The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia.

J Eswaran1, P Sinclair1, O Heidenreich1, J Irving1, L J Russell1, A Hall1, D P Calado2, C J Harrison1, J Vormoor3.   

Abstract

The B-cell receptor (BCR) and its immature form, the precursor-BCR (pre-BCR), have a central role in the control of B-cell development, which is dependent on a sequence of cell-fate decisions at specific antigen-independent checkpoints. Pre-BCR expression provides the first checkpoint, which controls differentiation of pre-B to immature B-cells in normal haemopoiesis. Pre-BCR signalling regulates and co-ordinates diverse processes within the pre-B cell, including clonal selection, proliferation and subsequent maturation. In B-cell precursor acute lymphoblastic leukaemia (BCP-ALL), B-cell development is arrested at this checkpoint. Moreover, malignant blasts avoid clonal extinction by hijacking pre-BCR signalling in favour of the development of BCP-ALL. Here, we discuss three mechanisms that occur in different subtypes of BCP-ALL: (i) blocking pre-BCR expression; (ii) activating pre-BCR-mediated pro-survival and pro-proliferative signalling, while inhibiting cell cycle arrest and maturation; and (iii) bypassing the pre-BCR checkpoint and activating pro-survival signalling through pre-BCR independent alternative mechanisms. A complete understanding of the BCP-ALL-specific signalling networks will highlight their application in BCP-ALL therapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25943180     DOI: 10.1038/leu.2015.113

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  115 in total

1.  Autoreactive B cell receptors mimic autonomous pre-B cell receptor signaling and induce proliferation of early B cells.

Authors:  Fabian Köhler; Eva Hug; Cathrin Eschbach; Sonja Meixlsperger; Elias Hobeika; Juliane Kofer; Hedda Wardemann; Hassan Jumaa
Journal:  Immunity       Date:  2008-12-11       Impact factor: 31.745

2.  Genomic analysis drives tailored therapy in poor risk childhood leukemia.

Authors:  Christine J Harrison
Journal:  Cancer Cell       Date:  2012-08-14       Impact factor: 31.743

3.  PTPN11 mutations in childhood acute lymphoblastic leukemia occur as a secondary event associated with high hyperdiploidy.

Authors:  C G Molteni; G Te Kronnie; S Bicciato; T Villa; M Tartaglia; G Basso; A Biondi; G Cazzaniga
Journal:  Leukemia       Date:  2009-09-24       Impact factor: 11.528

4.  Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site.

Authors:  T Oyake; K Itoh; H Motohashi; N Hayashi; H Hoshino; M Nishizawa; M Yamamoto; K Igarashi
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

5.  N-linked glycosylation selectively regulates autonomous precursor BCR function.

Authors:  Rudolf Ubelhart; Martina P Bach; Cathrin Eschbach; Thomas Wossning; Michael Reth; Hassan Jumaa
Journal:  Nat Immunol       Date:  2010-07-11       Impact factor: 25.606

6.  Malignant transformation of Slp65-deficient pre-B cells involves disruption of the Arf-Mdm2-p53 tumor suppressor pathway.

Authors:  Van B T Ta; Marjolein J W de Bruijn; Petra J ter Brugge; Jan Piet van Hamburg; Hans J A Diepstraten; Pieter Fokko van Loo; Rogier Kersseboom; Rudi W Hendriks
Journal:  Blood       Date:  2009-12-14       Impact factor: 22.113

7.  BCL6 is critical for the development of a diverse primary B cell repertoire.

Authors:  Cihangir Duy; J Jessica Yu; Rahul Nahar; Srividya Swaminathan; Soo-Mi Kweon; Jose M Polo; Ester Valls; Lars Klemm; Seyedmehdi Shojaee; Leandro Cerchietti; Wolfgang Schuh; Hans-Martin Jäck; Christian Hurtz; Parham Ramezani-Rad; Sebastian Herzog; Hassan Jumaa; H Phillip Koeffler; Ignacio Moreno de Alborán; Ari M Melnick; B Hilda Ye; Markus Müschen
Journal:  J Exp Med       Date:  2010-05-24       Impact factor: 14.307

8.  Erk kinases link pre-B cell receptor signaling to transcriptional events required for early B cell expansion.

Authors:  Tomoharu Yasuda; Hideki Sanjo; Gilles Pagès; Yohei Kawano; Hajime Karasuyama; Jacques Pouysségur; Masato Ogata; Tomohiro Kurosaki
Journal:  Immunity       Date:  2008-03-20       Impact factor: 31.745

9.  Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.

Authors:  Roland Schmitz; Ryan M Young; Michele Ceribelli; Sameer Jhavar; Wenming Xiao; Meili Zhang; George Wright; Arthur L Shaffer; Daniel J Hodson; Eric Buras; Xuelu Liu; John Powell; Yandan Yang; Weihong Xu; Hong Zhao; Holger Kohlhammer; Andreas Rosenwald; Philip Kluin; Hans Konrad Müller-Hermelink; German Ott; Randy D Gascoyne; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Martin D Ogwang; Steven J Reynolds; Richard I Fisher; Rita M Braziel; Raymond R Tubbs; James R Cook; Dennis D Weisenburger; Wing C Chan; Stefania Pittaluga; Wyndham Wilson; Thomas A Waldmann; Martin Rowe; Sam M Mbulaiteye; Alan B Rickinson; Louis M Staudt
Journal:  Nature       Date:  2012-08-12       Impact factor: 49.962

10.  Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project.

Authors:  Mignon L Loh; Jinghui Zhang; Richard C Harvey; Kathryn Roberts; Debbie Payne-Turner; Huining Kang; Gang Wu; Xiang Chen; Jared Becksfort; Michael Edmonson; Kenneth H Buetow; William L Carroll; I-Ming Chen; Brent Wood; Michael J Borowitz; Meenakshi Devidas; Daniela S Gerhard; Paul Bowman; Eric Larsen; Naomi Winick; Elizabeth Raetz; Malcolm Smith; James R Downing; Cheryl L Willman; Charles G Mullighan; Stephen P Hunger
Journal:  Blood       Date:  2012-12-04       Impact factor: 22.113

View more
  17 in total

1.  Immunophenotyping of Murine Precursor B-Cell Leukemia/Lymphoma: A Comparison of Immunohistochemistry and Flow Cytometry.

Authors:  Laura J Janke; Charles G Mullighan; Jinjun Dang; Jerold E Rehg
Journal:  Vet Pathol       Date:  2019-06-06       Impact factor: 2.221

2.  Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α.

Authors:  Marilena Pontoriero; Giuseppe Fiume; Eleonora Vecchio; Annamaria de Laurentiis; Francesco Albano; Enrico Iaccino; Selena Mimmi; Antonio Pisano; Valter Agosti; Emilia Giovannone; Annalisa Altobelli; Carmen Caiazza; Massimo Mallardo; Giuseppe Scala; Ileana Quinto
Journal:  J Mol Med (Berl)       Date:  2019-03-19       Impact factor: 4.599

3.  A new baby in the c-Myc-directed transcriptional machinery: Che-1/AATF.

Authors:  Valentina Folgiero; Cristina Sorino; Franco Locatelli; Maurizio Fanciulli
Journal:  Cell Cycle       Date:  2018-07-25       Impact factor: 4.534

4.  PTEN enables the development of pre-B acute lymphoblastic leukemia.

Authors:  Jérôme Fortin; Christian Bassi; Tak W Mak
Journal:  Nat Med       Date:  2016-04       Impact factor: 53.440

5.  Dynamic pre-BCR homodimers fine-tune autonomous survival signals in B cell precursor acute lymphoblastic leukemia.

Authors:  M Frank Erasmus; Ksenia Matlawska-Wasowska; Ichiko Kinjyo; Avanika Mahajan; Stuart S Winter; Li Xu; Michael Horowitz; Diane S Lidke; Bridget S Wilson
Journal:  Sci Signal       Date:  2016-11-29       Impact factor: 8.192

Review 6.  MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.

Authors:  Seyed Esmaeil Ahmadi; Samira Rahimi; Bahman Zarandi; Rouzbeh Chegeni; Majid Safa
Journal:  J Hematol Oncol       Date:  2021-08-09       Impact factor: 17.388

7.  Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K/AKT, FOXO1 and MYC, and can be targeted by SYK inhibition.

Authors:  S Köhrer; O Havranek; F Seyfried; C Hurtz; G P Coffey; E Kim; E Ten Hacken; U Jäger; K Vanura; S O'Brien; D A Thomas; H Kantarjian; D Ghosh; Z Wang; M Zhang; W Ma; H Jumaa; K-M Debatin; M Müschen; L H Meyer; R E Davis; J A Burger
Journal:  Leukemia       Date:  2016-02-05       Impact factor: 11.528

8.  The Expression Pattern of the Pre-B Cell Receptor Components Correlates with Cellular Stage and Clinical Outcome in Acute Lymphoblastic Leukemia.

Authors:  Dongfeng Chen; Junxiong Zheng; Natalija Gerasimcik; Kristina Lagerstedt; Helene Sjögren; Jonas Abrahamsson; Linda Fogelstrand; Inga-Lill Mårtensson
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

9.  Minimal Residual Disease Detection and Evolved IGH Clones Analysis in Acute B Lymphoblastic Leukemia Using IGH Deep Sequencing.

Authors:  Jinghua Wu; Shan Jia; Changxi Wang; Wei Zhang; Sixi Liu; Xiaojing Zeng; Huirong Mai; Xiuli Yuan; Yuanping Du; Xiaodong Wang; Xueyu Hong; Xuemei Li; Feiqiu Wen; Xun Xu; Jianhua Pan; Changgang Li; Xiao Liu
Journal:  Front Immunol       Date:  2016-10-04       Impact factor: 7.561

10.  High STAP1 expression in DUX4-rearranged cases is not suitable as therapeutic target in pediatric B-cell precursor acute lymphoblastic leukemia.

Authors:  Elisabeth M P Steeghs; Marjolein Bakker; Alex Q Hoogkamer; Judith M Boer; Quirine J Hartman; Femke Stalpers; Gabriele Escherich; Valerie de Haas; Hester A de Groot-Kruseman; Rob Pieters; Monique L den Boer
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.